Maider Da 2025 迈得医疗半年度报告 LEADER IN MEDICAL PRODUCTS AUTOMATION 医用耗材自动化领先者 迈得医疗工业设备股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细阐述经营过程中可能面临的风险及应对措施，有关内容敬请查阅第三 节"管理层讨论与分析"之"四、风险因素"。敬请投资者予以关注，审慎作出投资决定。 三、 公司全体董事出席董事会会议。 九、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 四、 本半年度报告未经审计。 五、 公司负责人林军华、主管会计工作负责人林君辉及会计机构负责人（会计主管人员）林君 辉声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计 ...

证券代码：688310 证券简称：迈得医疗 公告编号：2025-034 迈得医疗工业设备股份有限公司 2025年半年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 根据中国证券监督管理委员会《关于同意迈得医疗工业设备股份有限公司首 次公开发行股票注册的批复》（证监许可〔2019〕2019 号），中国证券监督管理 委员会同意公司首次公开发行股票的注册申请。公司于 2019 年 11 月首次公开发 行人民币普通股（A 股）股票 2,090 万股，每股面值人民币 1.00 元，每股发行价 格 24.79 元，募集资金总额为人民币 51,811.10 万元，扣除发行费用人民币 6,075.96 万元（不含税）后，募集资金净额为人民币 45,735.14 万元。该募集资金已于 2019 年 11 月 26 日到位。天健会计师事务所（特殊普通合伙）对公司本次公开发行新 股的资金到位情况进行了审验，并出具了天健验〔2019〕413 号《验 ...

迈得医疗工业设备股份有限公司 关于公司 2025 年度提质增效重回报专项行动方案的半 年度评估报告 迈得医疗工业设备股份有限公司（以下简称"公司"）为践行"以投资者为本"的上 市公司发展理念，推动公司持续优化经营、规范治理和积极回报投资者，大力提高 公司质量，助力信心提振、资本市场稳定和经济高质量发展，公司董事会审议通过 了《2025 年度"提质增效重回报"行动方案》。2025 年上半年，该行动方案执行情况 如下： 一. 聚焦经营主业 作为医用耗材智能装备的领先企业，公司具备智能装备与医疗器械产业的双重特 征，主要从事医用耗材智能装备的研发、生产、销售和服务，有效整合医疗器械产 品工艺、自动化、软件等方面的技术，形成独特的产品与服务优势，为医用耗材生 产企业提供自动化成套设备和软件服务整体式解决方案。公司始终坚持以"顾问式营 销、定向式研发、精细化生产、终身式服务"为经营方针，以"用心创造、推动医疗 器械产业升级"为使命，以"成为全球医用耗材自动化领先者"为愿景，围绕核心业务 积极寻求稳步扩张。 公司现已拥有成熟的、国内领先的安全输注类与血液净化类智能装备技术与优质 产品线，是国际上领先的透析器耗材设备供应商 ...

迈得医疗公告，2025年上半年营业收入1.41亿元，同比下降14.75%。净利润604.51万元，同比下降 38.81%。 ...

Market Overview - On August 27, the automation equipment sector declined by 1.04%, with MaiDe Medical leading the losses [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Stock Performance - Notable gainers in the automation equipment sector included: - MaiHe Co., Ltd. (301199) with a closing price of 30.73, up 4.59% [1] - Lianying Laser (688518) at 23.63, up 3.41% [1] - Bozhong Precision (688097) at 35.70, up 3.03% [1] - Conversely, significant decliners included: - MaiDe Medical (688310) at 19.23, down 6.24% [2] - Zhilifang (301312) at 52.80, down 5.78% [2] - Sitai Ke (301568) at 50.22, down 5.69% [2] Capital Flow - The automation equipment sector experienced a net outflow of 9.71 billion yuan from institutional investors, while retail investors saw a net inflow of 11.88 billion yuan [2][3] - Key stocks with notable capital flows included: - Huagong Technology (000988) with a net inflow of 76.58 million yuan from institutional investors [3] - Jintuo Co., Ltd. (300400) with a net inflow of 65.24 million yuan from institutional investors [3] - Zhilifang (301312) with a net outflow of 64.5 million yuan from institutional investors [3]

Group 1 - The core viewpoint of the news is that Maide Medical's stock has experienced a decline of 5.07%, with a current price of 19.47 CNY per share and a total market capitalization of 3.236 billion CNY [1] - Maide Medical, established on March 10, 2003, and listed on December 3, 2019, specializes in the research, production, sales, and service of medical consumables and intelligent equipment [1] - The main revenue composition of Maide Medical includes: 42.18% from safety infusion line machines, 37.90% from blood purification line machines, 14.04% from safety infusion single machines, and 5.87% from other categories [1] Group 2 - Among the top ten circulating shareholders of Maide Medical, a fund under Rongtong Fund holds a position, having reduced its holdings by 156 shares in the first quarter, now owning 2.5998 million shares, which is 1.56% of the circulating shares [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund (000727) has a current scale of 2.074 billion CNY and has achieved a return of 23.63% this year, ranking 3072 out of 8194 in its category [2] - The fund has a one-year return of 47%, ranking 2642 out of 7963, and a cumulative return since inception of 198.7% [2]

Market Overview - The Shanghai Composite Index is at 3884.87 points, above the five-day moving average, with a slight increase of 0.03% [1] - The total trading volume of A-shares is 21,403.55 billion yuan [1] Stocks Breaking the Five-Day Moving Average - A total of 832 A-shares have surpassed the five-day moving average today [1] - Notable stocks with significant deviation rates include: - Jiaheng Home (300955) with a deviation rate of 14.97% and a daily increase of 20.02% [1] - Jiuqi Co. (300994) with a deviation rate of 14.66% and a daily increase of 19.99% [1] - Maide Medical (688310) with a deviation rate of 12.65% and a daily increase of 18.99% [1] Additional Stocks with Notable Performance - Other stocks with significant performance include: - Haosheng Electronics (838701) with a deviation rate of 10.52% and a daily increase of 14.32% [1] - Tianrun Technology (430564) with a deviation rate of 9.72% and a daily increase of 12.42% [1] - Jieput (688025) with a deviation rate of 9.12% and a daily increase of 12.28% [1]

Group 1 - The core point of the news is that MaiDe Medical's stock experienced a significant increase, reaching a limit up of 20.00% during trading on August 26, with a price of 21.30 yuan and a trading volume of 2.05 billion yuan [2] - Among the stocks listed on the Sci-Tech Innovation Board, a total of 262 stocks were reported to be rising, with 10 stocks showing an increase of over 10%, including MaiDe Medical, KaiPu Cloud, and Electric Wind Power [2] - Conversely, 315 stocks were reported to be declining, with notable decreases in stocks such as JingSong Intelligent, ShengKe Communication-U, and Chip Origin, which fell by 9.41%, 9.20%, and 9.02% respectively [2] Group 2 - In terms of capital flow, MaiDe Medical saw a net outflow of 27.82 million yuan in the previous trading day, with a total net outflow of 40.42 million yuan over the past five days [3] - The latest margin trading data as of August 25 indicates that the margin balance for MaiDe Medical is 73.09 million yuan, which represents a decrease of 0.37% from the previous trading day [3] - Over the past ten days, the total margin balance has increased by 10.06 million yuan, reflecting a growth rate of 15.97%, with the financing balance also growing by the same percentage [3]

Group 1 - The core point of the news is that Maide Medical has seen an increase in financing buy-in amounts over the recent trading days, indicating growing investor interest [1] - On August 22, Maide Medical recorded a financing buy-in amount of 0.16 billion, ranking 1250th in the market, with a financing repayment amount of 0.11 billion, resulting in a net buy-in of 4.39 million [1] - Over the last three trading days from August 20 to August 22, the financing buy-in amounts for Maide Medical were 0.03 billion, 0.08 billion, and 0.16 billion respectively, showing a consistent upward trend [1] Group 2 - In terms of securities lending, on the same day, there were no shares sold or net sold, indicating no activity in this area for Maide Medical [2]

Core Viewpoint - The stock of Maide Medical (688310) has shown a significant increase of 4.67% on August 21, 2025, closing at 18.59 yuan, despite a net outflow of major funds [1][2]. Financial Performance - Maide Medical reported a main revenue of 40.18 million yuan for Q1 2025, a year-on-year decline of 45.87% [4]. - The net profit attributable to shareholders was -10.80 million yuan, representing a year-on-year decrease of 202.7% [4]. - The company’s gross profit margin stands at 32.89%, which is higher than the industry average of 27.3% [4]. Market Position - The total market capitalization of Maide Medical is 3.09 billion yuan, significantly lower than the industry average of 7.58 billion yuan [4]. - The company ranks 202nd out of 265 in terms of total market value within the specialized equipment industry [4]. - The price-to-earnings ratio (P/E) is -71.55, indicating negative earnings, while the industry average is 81.71 [4]. Fund Flow Analysis - On August 21, 2025, the net outflow of major funds was 2.41 million yuan, accounting for 1.89% of the total transaction amount [1]. - Retail investors showed a net inflow of 2.95 million yuan, representing 2.30% of the total transaction amount on the same day [1]. - Over the past five days, the trend indicates a consistent net outflow from major funds, with a total net outflow of 4.43 million yuan on August 20, 2025 [1][2]. Financing and Margin Trading - As of August 21, 2025, the financing balance is 68.97 million yuan, with a net repayment of 10.46 million yuan on that day [2]. - There were no shares sold or repaid in the margin trading segment, indicating no activity in this area [2].